1.
Infection
; 45(1): 115-117, 2017 Feb.
Article
in English
| MEDLINE
| ID: mdl-27670678
ABSTRACT
INTRODUCTION: Ceftolozane/tazobactam is a novel antibiotic approved for the treatment of complicated intra-abdominal and complicated urinary tract infections. CASE DESCRIPTION: We describe the use of off-label ceftolozane/tazobactam in the management of a multidrug-resistant Pseudomonas aeruginosa bacteremia that was already being treated with colistin and amikacin, the only active antibiotics according to the antibiogram.
Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacteremia , Cephalosporins/therapeutic use , Penicillanic Acid/analogs & derivatives , Pseudomonas Infections , Pseudomonas aeruginosa/drug effects , Anti-Bacterial Agents/pharmacology , Bacteremia/drug therapy , Bacteremia/epidemiology , Bacteremia/microbiology , Cephalosporins/pharmacology , Drug Resistance, Multiple, Bacterial , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Off-Label Use , Penicillanic Acid/pharmacology , Penicillanic Acid/therapeutic use , Pseudomonas Infections/drug therapy , Pseudomonas Infections/epidemiology , Pseudomonas Infections/microbiology , Tazobactam
2.
Stroke
; 39(4): e67; auhtor reply e68, 2008 Apr.
Article
in English
| MEDLINE
| ID: mdl-18309165